Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and diseaseFU, Tong-Ming; ZHIQIANG AN; DAI WANG et al.Vaccine. 2014, Vol 32, Num 22, pp 2525-2533, issn 0264-410X, 9 p.Article

Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in miceXAIOPING LIANG; FU, Tong-Ming; HONG XIE et al.Vaccine. 2002, Vol 20, Num 27-28, pp 3413-3421, issn 0264-410X, 9 p.Article

Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic NeutralizationKATPALLY, Umesh; FU, Tong-Ming; FREED, Daniel C et al.Journal of virology. 2009, Vol 83, Num 14, pp 7040-7048, issn 0022-538X, 9 p.Article

Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulationsFREED, Daniel C; TOWNE, Victoria M; CASIMIRO, Danilo R et al.Vaccine. 2011, Vol 29, Num 50, pp 9385-9390, issn 0264-410X, 6 p.Article

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing GagCASIMIRO, Danilo R; FUBAO WANG; BAGCHI, Ansu et al.Journal of virology. 2005, Vol 79, Num 24, pp 15547-15555, issn 0022-538X, 9 p.Article

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1FU, Tong-Ming; DUBEY, Sheri A; GOEPFERT, Paul A et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 67-76, issn 0889-2229, 10 p.Article

Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursorBIANCHI, Elisabetta; XIAOPING LIANG; MANGER, Walter et al.Journal of virology. 2005, Vol 79, Num 12, pp 7380-7388, issn 0022-538X, 9 p.Article

Use of overlapping peptide mixtures as antigens for cytokine flow cytometryMAECKER, Holden T; DUNN, Holli S; BREDT, Barry M et al.Journal of immunological methods. 2001, Vol 255, Num 1-2, pp 27-40, issn 0022-1759Article

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectorsCASIMIRO, Danilo R; BETT, Andrew J; GURUNATHAN, Sanjay et al.Journal of virology. 2004, Vol 78, Num 20, pp 11434-11438, issn 0022-538X, 5 p.Article

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysJIANG FAN; XIAOPING LIANG; GARSKY, Victor M et al.Vaccine. 2004, Vol 22, Num 23-24, pp 2993-3003, issn 0264-410X, 11 p.Article

Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infectionDAI WANG; FENGSHENG LI; FREED, Daniel C et al.Vaccine. 2011, Vol 29, Num 48, pp 9075-9080, issn 0264-410X, 6 p.Article

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysFU, Tong-Ming; GRIMM, Karen M; CITRON, Michael P et al.Vaccine. 2009, Vol 27, Num 9, pp 1440-1447, issn 0264-410X, 8 p.Article

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunitySHIVER, John W; FU, Tong-Ming; LINGYI HUANG et al.Nature (London). 2002, Vol 415, Num 6869, pp 331-335, issn 0028-0836Article

A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccinesTANG, Aimin; FENGSHENG LI; FREED, Daniel C et al.Vaccine. 2011, Vol 29, Num 46, pp 8350-8356, issn 0264-410X, 7 p.Article

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continentsCOPLAN, Paul M; GUPTA, Swati B; FU, Tong-Ming et al.The Journal of infectious diseases. 2005, Vol 191, Num 9, pp 1427-1434, issn 0022-1899, 8 p.Article

High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8⁺ T-cell expansion but improved virus controlDAVENPORT, Miles P; LEI ZHANG; BAGCHI, Ansuman et al.Journal of virology. 2005, Vol 79, Num 15, pp 10059-10062, issn 0022-538X, 4 p.Article

Vectored gag and env but not tat show efficacy against simian-human immunodeficiency virus 89.6p challenge in Mamu-A*01-negative rhesus monkeysXIAOPING LIANG; CASIMIRO, Danilo R; HEIDECKER, Gwendolyn et al.Journal of virology. 2005, Vol 79, Num 19, pp 12321-12331, issn 0022-538X, 11 p.Article

Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A virusesWEIMIN ZHONG; JU HE; XIAOLING TANG et al.Journal of immunological methods. 2011, Vol 369, Num 1-2, pp 115-124, issn 0022-1759, 10 p.Article

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assayDUBEY, Sheri; CLAIR, James; LAN ZHU et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 1, pp 20-27, issn 1525-4135, 8 p.Article

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaquesCAPONE, Stefania; MEOLA, Annalisa; FU, Tong-Ming et al.Journal of virology. 2006, Vol 80, Num 4, pp 1688-1699, issn 0022-538X, 12 p.Article

A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV type 1 gag vaccinated human subjectsTOBERY, Timothy W; DUBEY, Sheri A; FU, Tong-Ming et al.AIDS research and human retroviruses. 2006, Vol 22, Num 11, pp 1081-1090, issn 0889-2229, 10 p.Article

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationBAROUCH, Dan H; SANTRA, Sampa; BEAUDRY, Kristin et al.Science (Washington, D.C.). 2000, Vol 290, Num 5491, pp 486-492, issn 0036-8075Article